Remission, Relapse, and Persistence of Vulvodynia: A Longitudinal Population-Based Study
- PMID: 26752153
- PMCID: PMC4790209
- DOI: 10.1089/jwh.2015.5397
Remission, Relapse, and Persistence of Vulvodynia: A Longitudinal Population-Based Study
Abstract
Background: Vulvodynia has been considered to be a chronic disorder. We sought to estimate the probability of and risk factors for remission, relapse, and persistence among women screening positive for vulvodynia.
Methods: Survey-based assessment in a longitudinal population-based study of women (the Woman to Woman Health Study) who screened positive for vulvodynia and completed at least four follow-up surveys. Outcome measures included remission without relapse, relapse (after remission), and persistence of a positive vulvodynia screen. Multinomial regression was used to assess factors associated with outcomes.
Results: Of 441 women screening positive for vulvodynia during the study, 239 completed 4 additional surveys. Of these, 23 (9.6%) had consistently positive vulvodynia screens, 121 (50.6%) remitted without relapse, and 95 (39.7%) relapsed following remission. Overall, factors associated with both relapse and persistence (compared with remission alone) included increased severity of pain ever (p < 0.001) or after intercourse (p = 0.03), longer duration of symptoms (p ≤ 0.001), and screening positive for fibromyalgia (p < 0.001). Factors associated with persistence (but not relapse) included more severe symptoms with intercourse (p = 0.001) and pain with oral sex (p = 0.003) or partner touch (p = 0.04). Factors associated with relapse (but not persistence) included having provoked pain (p = 0.001) or screening positive for interstitial cystitis (p = 0.05) at first positive vulvodynia screen. Demographic characteristics, age at pain onset, and whether vulvodynia was primary or secondary did not predict outcome.
Conclusion: Remission of vulvodynia symptoms is common with approximately half of remitters experiencing a relapse within 6-30 months. Persistence without remission is the exception rather than the rule. Pain history and comorbid conditions were associated with the more severe outcomes of relapse and/or persistence compared with those who remitted only. These findings provide further support that vulvodynia is heterogeneous and often occurs in an episodic pattern.
Figures
References
-
- McKay M, Frankman O, Horowitz BJ, et al. . Vulvar vestibulitis and vestibular papillomatosis. Report of the ISSVD Committee on vulvodynia. J Reprod Med 1991;36:413–415 - PubMed
-
- Bachmann GA, Rosen R, Pinn VW, et al. . Vulvodynia: A state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med 2006;51:447–456 - PubMed
-
- Haefner HK, Collins ME, Davis GD, et al. . The vulvodynia guideline. J Low Genit Tract Dis 2005;9:40–51 - PubMed
-
- Reed BD, Haefner HK, Cantor L. Vulvodynia (Vulvar dysesthesia)—A follow-up study. J Reprod Med 2003;48:409–416 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
